Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cell-bound complement activation products associate with lupus severity in SLE.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cell-bound complement activation products associate with lupus severity in SLE.
Cell-bound complement activation products associate with lupus severity in SLE. Lupus Sci Med. 2020 04; 7(1).
View in:
PubMed
subject areas
Adolescent
Adult
B-Lymphocytes
Case-Control Studies
Complement Activation
Complement C3
Complement C4
Cross-Sectional Studies
Erythrocytes
Female
Flow Cytometry
Humans
Immunosuppressive Agents
Lupus Erythematosus, Systemic
Male
Middle Aged
Severity of Illness Index
Young Adult
authors with profiles
Cristina Arriens
Judith A James